The AllCells Blog

AllCells Blog

AllCells blog posts are dedicated to highlighting scientific trends, innovation, and technological advances within the biomedical industry. Data-driven studies and primary research are conducted to create our blogs and include experts within the following fields: immuno-oncologists, cell and gene therapy, academia, government, and contract research organizations.

The Key to Developing Good Manufacturing Practice (GMP) Biomaterials for Cell and Gene Therapy Development

October 3, 2022

A decade ago, the emergence of new immunotherapies in the cell and gene therapy (CGT) space opened up new avenues to treat disease, sparking excitement across the industry. However, the […]

Overcoming the Global Biomaterial Supply Chain Challenge for the Development of CAR-T Therapies

September 21, 2022

By 2026, commercial chimeric antigen receptor (CAR)-T cell therapies are on track to make up the largest share of oncology drug sales for pediatric and young adult patients1. This is […]

Dual Mobilization Enhances CD34+ Yield Across All Donor Types

August 1, 2022

Mobilized peripheral blood has now surpassed bone marrow as the preferred source of CD34+ hematopoietic stem and progenitor cells (HSPCs) for allogeneic hematologic transplantation and translational medicines because both the […]

The Therapeutic Potential of HSC-based Gene Therapies

July 25, 2022

Hematopoietic stem cells (HSCs) have immense therapeutic potential because of their ability for both self-renewal and multi-lineage differentiation to maintain hematopoietic homeostasis. This rare population of cells are characterized by […]

A Decade of Innovation: CAR-T Successes and Latest Developments

July 6, 2022

After a decade of innovation, chimeric antigen receptor (CAR)-T cell therapy remains at the forefront of the cell and gene therapy space, continuing to forge new ground to treat previously […]

Cell Therapy

Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development

May 24, 2022

Cell and gene therapies represent an expanding category of transformative medicines with the potential to change the way we treat human diseases. Broadly, these novel therapies include both in vivo […]

Dna Double Helix

What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends

April 20, 2022

Growth in the Regenerative Medicine Field The regenerative medicine sector is on track for another watershed year where clinical progress, continued growth, and segmentation into new disease areas affecting larger […]

Donor Management Services

A Donor-Centric Approach to Cell and Gene Therapy

February 3, 2022

In the past decade, emerging therapeutic modalities like cell and gene therapies have opened up new treatment options for previously intractable diseases, changing the industry needs for primary tissues. While […]


AllCells Announces First to Market Launch of In Stock GMP Cryopreserved Leukopaks

January 28, 2022

Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP Cryopreserved Leukopaks significantly decrease lead time   AllCells, the industry leader in […]

AllCells cryopreserved cells in vial

FAQ Series: The Science Behind Cryopreservation

January 11, 2022

Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]

Customer Service

How Can We Help You?

Looking for research tips? Need help sourcing materials? How about a few more articles on therapies or processes? At AllCells, we believe that partnerships create the best pathways to success. Our Customer Success Team has years of industry experience and a wealth of resources to help you get the most out of your cellular products. We’re only a few clicks away.

Contact Us
Have a question? Let’s chat.